Why we age: the six theories that converge on inflammation.

Roughly 300 theories of aging have been proposed in the medical literature over the last century. Six have stayed in clinical conversation long enough to matter: Free Radical Theory, Mitochondrial Decline, the Neuroendocrine Theory, Cross-Linking and Glycation, Genetic Control, and the Telomere Theory. Each frames the upstream mechanism of aging differently. None is the complete picture on its own. But all six converge — eventually, mechanistically, durably — on the same downstream pathway: chronic, low-grade inflammation. And chronic inflammation is what drives the diseases that define old age — atherosclerosis, dementia, cancer, type-2 diabetes, hypertension, osteoporosis, osteoarthritis, and the rest.

That convergence is the through-line of this post. The six theories are interesting on their own; the convergence is what makes them clinically useful.

Why this matters at the patient level: most of conventional medicine intervenes after the named diseases show up. Proactive medicine — the kind Dr. Castellano practices in Orange County — works upstream of the diseases, on the mechanisms themselves: hormones, mitochondria, metabolic markers, oxidative stress, glycation, inflammation. When the upstream picture stays in range, the downstream conditions tend to stay further away. Not preventable in the FDA sense of the word, but moveable in the population-evidence sense.

The rest of this post walks through the six theories, the inflammation through-line, the disease list that sits downstream, and how the practice’s four pillars of anti-aging care map to the mechanisms involved.

The two categories — programmed vs. damage

The six theories fall into two broad categories.

Programmed Aging Theories treat aging as a precise, gene-driven sequence — an internal clock that ticks at a pre-set rate, with hormones and DNA orchestrating the timing of age-related decline. The Neuroendocrine Theory and the Telomere Theory belong here. In this view, aging is a controlled process — built into the system, not the byproduct of accumulated damage from outside.

Accidental / Damage Theoriestreat aging as the cumulative result of environmental and metabolic insults — radiation, chemical toxins, metal ions, free-radical byproducts, glycation. Damage accrues across genes, proteins, cell membranes, enzymes, and blood vessels. The Free Radical, Mitochondrial Decline, Cross-Linking, and (partly) Genetic Control theories belong here. This is why elderly patients can’t tolerate stresses or fight off illness the way they could in their twenties — the accumulated damage has narrowed the margin.

Most modern thinking accepts that both categories are true at the same time. There’s a programmed component (the body has a built-in trajectory) and an accidental component (the trajectory accelerates or slows with how the body is treated). The clinical implication is the same either way: the trajectory is partially modifiable.

Free Radical Theory of Aging

Developed by Denham Harman, MD, in 1954, the Free Radical Theory proposes that organisms age due to the accumulation of damage from free radicals — molecules with a single unpaired electron that make them aggressively reactive.

Free radicals are unavoidable byproducts of energy production. Mitochondria — the cellular structures that make ATP — generate free radicals as a routine consequence of running the electron transport chain. Most are neutralized internally by the body’s antioxidant defenses; the ones that escape attack the structure of cell membranes, where they create metabolic waste products that interfere with cell-to-cell communication, disturb DNA and RNA replication, disrupt protein synthesis, lower cellular energy levels, and degrade the chemistry that keeps the cell working.

Over decades, that damage compounds — slowly enough that nothing dramatic happens at any one moment, consistently enough that the older the organism gets, the harder the cell has to work to maintain baseline function.

Antioxidants — vitamins A, C, and E among them — have been shown to play a role in the body’s response to oxidative stress. The contemporary view is more nuanced than Harman’s 1954 framing: reactive oxygen species are not purely destructive byproducts but pleiotropic signaling agents — useful at low levels, damaging at sustained high levels (Sies & Jones, 2020 — Reactive oxygen species (ROS) as pleiotropic physiological signalling agents, Nature Reviews Molecular Cell Biology).

The clinical implication for the practice’s anti-aging lane is not to eliminate free-radical formation — that’s biologically impossible — but to keep the redox balance tilted toward repair rather than damage. That’s what micronutrient correction (vitamin D, B12, magnesium, antioxidant adequacy) and metabolic correction (insulin sensitivity, lipid panel, body composition) are designed to do over time.

Mitochondrial Decline Theory of Aging

If free radicals are the bullets, the mitochondria are the room they’re fired in. Each cell carries hundreds to thousands of mitochondria — the cellular structures that produce adenosine triphosphate (ATP), the universal energy currency the body runs on. Every thought, every muscle contraction, every immune response is paid for in ATP.

The mitochondria produce most of the body’s free radicals as a byproduct of running the electron transport chain — the same process that produces the ATP. Unlike the rest of the cell, the mitochondria don’t have robust internal defenses against the free radicals they themselves generate. Damage accumulates over time. As mitochondria become damaged, they become less efficient — producing less ATP per unit of substrate, leaking more electrons, generating more free radicals, damaging more mitochondria. The cycle compounds.

As mitochondrial function declines, so does the function of the organ the mitochondria support. ATP production falls; cells lose the capacity to repair themselves; tissue function progressively narrows. This pattern contributes to the organ-system-level decline characteristic of late-life disease — gradual loss of function in heart muscle (cardiovascular disease), neurons (cognitive decline), pancreatic beta cells (insulin resistance and type-2 diabetes), and most other tissue compartments.

The practice’s intervention points here are indirect but real. Hormone optimization — particularly hormone replacement where the labs warrant it — supports mitochondrial biogenesis. Metabolic correction reduces the substrate-overload that accelerates mitochondrial damage. The relevance of medical weight loss is here too: insulin resistance is a major upstream driver of mitochondrial dysfunction, and addressing one moves the other. Targeted compounds investigated in the longevity literature — coenzyme Q10, alpha-lipoic acid, certain B-vitamins — show promise as supportive nutrients in published reviews, though evidence quality varies, and peptide adjuncts are considered case-by-case rather than as standing protocols.

Neuroendocrine Theory of Aging

Developed by Professor Vladimir Dilman and Ward Dean, the Neuroendocrine Theory holds that aging is driven by an age-related loss of central (hypothalamic) and peripheral receptor sensitivity to hormones and other signaling molecules. As the hypothalamus loses its responsiveness to feedback signals, the body’s regulatory system drifts progressively off-target — hormone levels shift, neurotransmitter balance shifts, and the cell-signaling cascades that depend on tight calibration begin to misfire.

Ward Dean, M.D., framed it this way:

“The aging process is caused by an age-related loss of central (hypothalamic) and peripheral receptor sensitivity to inhibition by hormones and other signaling substances. This loss of hypothalamic sensitivity results in a progressive shifting of homeostasis — the body’s regulatory system for maintaining internal balance — and altered levels of hormones, neurotransmitters, and cell signalers. These metabolic shifts are believed to cause aging and the diseases of aging.”

Or, in the more rhetorically pointed inversion from Dr. Ron Rothenburg in Forever Ageless:

“We age because our hormones decline; our hormones don’t decline because we age.”

This inversion has shaped much of the modern hormone-replacement conversation. Whether it captures the full causal arc is debated in the literature — but the directional point about the upstream role of hormone decline is clinically well-established.

The practical reality: as the HPGA axis (hypothalamic–pituitary–gonadal–adrenal) ages, secretion of growth hormone, thyroid hormone, DHEA, melatonin, testosterone, and estrogen all decline — and the receptors for those hormones become less responsive even at normal serum levels. Patients produce less, AND what gets produced works less effectively.

Cortisol moves the opposite direction. It rises with chronic stress and age. Cortisol is necessary at acute peaks (the fight-or-flight response) but damaging when sustained. Sustained cortisol can reduce neuronal uptake of glucose by 15–25%, impairing the energy supply to neurons over time (Lupien et al., 2009 — Effects of stress throughout the lifespan on the brain, behaviour and cognition, Nature Reviews Neuroscience). Combined with chronic hypothalamic stress, the result is a feedback loop: cortisol damages hypothalamic regulation, the hypothalamus loses feedback control, more cortisol gets produced, more damage accrues.

This theory is the clinical engine behind Testosterone Replacement Therapy and Hormone Support Therapy at the practice — both work upstream of the cascade, addressing the hormone-decline arm of the problem before the diseases of aging consolidate downstream.

Cross-Linking / Glycation Theory of Aging

In this theory, the upstream insult is sugar — specifically, the binding of glucose to protein molecules to form what biochemists call advanced glycation end-products (AGEs). Once a protein has been glycated, it changes character. It becomes sticky. It begins adhering to other proteins, cross-linking with them, leaving deposits in vital tissues and inhibiting whatever job those proteins were originally designed to do.

The longer a person lives, the more cross-linked their long-lived structural proteins become. Connective tissue stiffens. Skin loses elasticity. Arterial walls calcify. Lens proteins in the eye become opaque. The same biology drives joint changes, kidney filtration changes, and the gradual narrowing of vessel patency that defines vascular aging.

Diabetics show what accelerated glycation looks like. During sustained hyperglycemia, AGE formation can increase several-fold versus normal blood-sugar profiles. This is why patients with diabetes suffer the premature onset of a wide range of age-related complications — cataracts, retinopathy, neuropathy, nephropathy, atherosclerosis, and osteoporosis among them. People with diabetes accumulate roughly two to three times the cross-linked proteins of their non-diabetic peers, which is the reason the literature increasingly describes diabetes as a form of accelerated aging (Kim et al., 2017 — Glycation in the pathogenesis of aging and aging-related disease, PMC5643203).

The clinical lever here is metabolic correction — keeping fasting glucose, fasting insulin, and HbA1c in range so the body’s protein structures aren’t constantly being attacked by sugar. The practice’s standard panel screens for it specifically: fasting glucose, HbA1c, fasting insulin alongside the hormone panel, with medical weight loss available where insulin resistance and body-composition drift are central to the picture.

Genetic Control Theory of Aging

DNA is the blueprint each person inherits. Each of us is born with a unique genetic code and a predetermined tendency toward certain physical and biochemical patterns — including a baseline rate at which the body ages.

But the genetic clock is more modifiable than it sounds. DNA is easily oxidized, and that damage accumulates from diet, lifestyle, environmental toxins, pollution, radiation, alcohol, smoking, sleep deficit, and other inputs the patient controls. Free radicals damage DNA. Glycation damages DNA. Hormones — through their effects on gene expression and DNA repair pathways — also influence how the genome functions at the cellular level.

Each of these is something a patient can directly affect. Diet decisions, training cadence, sleep cadence, alcohol intake, and screening for and correcting metabolic and hormonal imbalances all either accelerate or slow the rate at which the genetic clock runs.

The clinical relevance is straightforward: a patient inherits a baseline trajectory; how that trajectory plays out depends substantially on the inputs over the next 30+ years. The genetic deck is dealt at birth, but the cards get played decade by decade. The practice’s four pillars of anti-aging care — hormone optimization, metabolic correction, micronutrient repletion, lifestyle scaffolding — are the levers that move the played hand.

Telomere Theory of Aging

Telomeres are repetitive DNA sequences at the ends of each chromosome. Their job is structural: they protect the chromosomes from damage during cell division, and they prevent the chromosomes from fusing into rings or binding to other DNA in the cell nucleus.

When a cell divides, the chromosomes are copied — but the telomeres at each end shorten with every replication. This isn’t a bug; it’s a feature of how DNA replication works. Eventually, after enough divisions, the telomeres become too short for further replication. The cell stops dividing. It can keep functioning for years in this growth-arrested state — biologists call it cellular senescence — but it can no longer replenish the tissue around it. This is the Hayflick Limit, named for the researcher who first described it.

In aggregate, across millions of cells in dozens of tissues, this is what aging looks like at the chromosomal level: a steady reduction in the body’s capacity to replace damaged cells with fresh ones.

The intervention space here is more limited than for the other theories — telomere length itself is not directly modifiable through standard clinical care. But the upstream factors that accelerate telomere shortening (oxidative stress, glycation, chronic inflammation, hormone decline) are modifiable, and addressing them slows the rate of telomere attrition over time. Indirect mechanism, real effect.

The aspirational view — Aubrey de Grey

Aubrey de Grey, Ph.D., a biomedical gerontologist at the University of Cambridge, framed the aspirational endpoint of aging research this way:

“Repair of the cellular and molecular damage known as aging is something we may soon be able to do. The first repairs will be incomplete, but if we are partially rejuvenated, we may live long enough to receive more complete repair as it becomes available.”

This is one researcher’s framing of where the science is headed. It remains an aspirational projection, not current clinical practice — and de Grey’s specific hypotheses about which damage targets are tractable have been debated by other gerontologists. The point of including the quote here is not that the practice offers what de Grey describes (it doesn’t, and no clinic does), but that the modern anti-aging conversation is partly shaped by the assumption that early-stage interventions accumulate compounding returns over decades. The practical version of that assumption — start the work earlier, correct what the labs say is correctable, stay alive long enough for the science to catch up — is the practice’s everyday clinical lane.

The convergence — chronic inflammation as the common downstream pathway

This is the part that ties the six theories together. Each theory frames the upstream insult differently — free radicals, mitochondrial dysfunction, hormone decline, glycation, genetic damage, telomere attrition — but each ends up at the same downstream signal: chronic, low-grade inflammation that the body cannot fully resolve.

The aging body progressively accumulates inflammatory markers — TNF-α, IL-1, IL-6, hs-CRP — even in the absence of overt infection or injury. The literature now calls this inflammaging: chronic, low-grade, sterile inflammation that emerges with age and contributes to nearly every age-related disease (Franceschi et al., 2018 — Inflammaging: a new immune-metabolic viewpoint for age-related diseases, Nature Reviews Endocrinology).

The most comprehensive recent synthesis — The hallmarks of aging: an expanding universe (López-Otín et al., 2023, Cell) — identifies twelve hallmarks of aging that interact and overlap, with chronic inflammation as one of the integrative hallmarks that consolidates upstream damage into late-life disease. The theories above are precursors and contributors to these hallmarks — the hallmarks paper expands and formalizes the same fundamental claim: that aging is a network of interlocking failures, and inflammation is where they meet.

Two practical consequences follow. First: an anti-aging intervention that addresses one mechanism in isolation (just antioxidants, just hormones, just calorie restriction) tends to underperform an intervention that addresses several at once. The mechanisms compound, and so do the interventions that move them. Second: the inflammatory load itself is something the body’s own systems are actively trying to manage — and that capacity is also age-dependent. Lifetime exposure to infectious diseases, sustained metabolic stress, sleep deprivation, and chronic psychological stress all reduce the body’s reserve to clear inflammation as it accumulates.

The patients who age the best, in the literature and in the practice’s three-decade case file, are the ones whose inputs across all four pillars stay in range over time. None of the levers is dramatic individually; the combination, sustained, is what compounds.

The diseases of aging — what’s downstream

The list below is the partial set of conditions that the medical literature most consistently associates with the upstream mechanisms above:

• Atherosclerosis (plaquing of the arteries)
• Cancer
• Dementia — Alzheimer’s disease and vascular dementia
• Parkinson’s disease
• Essential hypertension
• Type-2 diabetes mellitus
• Cataracts
• Stroke
• Osteoporosis
• Osteoarthritis

These are conditions every adult patient should expect to encounter in someone close to them — and, statistically, one or more of them themselves over a long-enough timeline. The current medical system is set up to treat these conditions once they’ve manifested, not before. For most of medical history, that was the only feasible posture: the upstream mechanisms weren’t well-understood, the lab markers weren’t routinely measured, and the interventions weren’t yet validated.

That’s no longer the only option. The hormone, metabolic, micronutrient, and inflammation markers that sit upstream of these conditions can now be measured in routine bloodwork, tracked over time, and corrected when they drift. Proactive medicine — anchored in lab-driven hormone optimization, metabolic correction, and the boring fundamentals — is associated with better trajectories across the markers most associated with the diseases of aging in published longevity research.

The practice doesn’t promise prevention of any specific disease. The honest framing is to support the trajectories that the population-level data tracks, address what the labs say is correctable, and stay aware of where modern medicine genuinely can intervene versus where it can’t.

What this means at the practice level

The practice’s anti-aging lane is built around four pillars that map directly to the upstream mechanisms above:

• Hormone optimization — testosterone replacement for men where bloodwork warrants it, bioidentical hormone replacement for women, and broader hormone support therapy for patients whose picture sits outside straight TRT criteria. This is the Neuroendocrine theory’s clinical lane.
• Metabolic correction — fasting glucose, HbA1c, fasting insulin, lipid panel (including ApoB where indicated), inflammatory markers like hs-CRP. Corrected through nutrition, training, targeted medication where warranted, and (where appropriate) medical weight loss. This is the Glycation and Mitochondrial-Decline lane.
• Micronutrient repletion — vitamin D, B12, iron / ferritin, magnesium, and the antioxidant nutrients that support redox balance. Boring, cheap to fix, surprisingly load-bearing. This is the Free Radical lane.
• Lifestyle scaffolding— sleep cadence, training consistency, alcohol moderation, daily movement, stress recovery. Three decades of clinical practice show that this pillar — by far the least glamorous — differentiates patients who arrive in their seventies still strong from those who don’t. It’s also what the Genetic Control theory points to: the levers that compound over decades against the inherited baseline.

The practice doesn’t run stem-cell IVs, NAD drips, premium supplement stacks, or aesthetic injectables. The lane is the medical version of anti-aging: lab-driven, mechanism-targeted, conservative on what isn’t yet established. For the science, the patients, and the long-form trajectories the data tracks, that’s the version of the work that compounds.

Frequently asked questions